Xiuping Liang
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Research progress of mesenchymal stem cells/stromal cells and their derivatives against cell senescence in the treatment of osteoarthritis.
Journal: Annals of medicine
Published: April 01, 2026
The TREM2 paradox in fibrosis: a unified mechanism for opposite outcomes across organs.
Journal: Frontiers in immunology
Published: January 29, 2026
Reply: "Toward a more translational SS-ILD model: Sex differences, endpoints, and B cell targets".
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 11, 2025
Correction: Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications.
Journal: Frontiers in immunology
Published: December 05, 2025
Mesenchymal stem cell-derived microvesicles confer protection against rheumatoid arthritis-associated interstitial lung disease.
Journal: Stem cell research & therapy
Published: December 02, 2025
Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications.
Neutrophils as key drivers of pulmonary fibrosis: unveiling mechanisms and therapeutic implications.
Journal: Frontiers in immunology
Published: October 03, 2025
Establishment of a mouse model of Sjögren syndrome-related interstitial lung disease.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 07, 2025
Prediction of intravenous cyclophosphamide treatment efficacy in idiopathic inflammatory myopathies-associated interstitial lung disease patients: a nomogram based on radiomics and clinical factors.
Journal: BMC pulmonary medicine
Published: April 07, 2025
A nomogram for the prediction of co-infection in MDA5 dermatomyositis: A rapid clinical assessment model.
Journal: Clinical immunology (Orlando, Fla.)
Published: November 26, 2024
Human umbilical cord mesenchymal stem cell-derived microvesicles alleviate pulmonary fibrosis by inhibiting monocyte‒macrophage migration through ERK1/2 signaling-mediated suppression of CCL2 expression.
Journal: Stem cell research & therapy
Published: May 21, 2024
Interplay between COVID-19 and Secukinumab treatment in Spondylarthritis patients during the omicron surge: a retrospective cohort study.
Journal: Autoimmunity
Published: December 14, 2023
Last Updated: 09/26/2026